Weighing risks and rewards en route to the clinic
Christopher T Scott
Does stem cell therapy contain too many unknowns to move into human clinical trials?
Published online: 18 December 2008; doi:10.1038/stemcells.2008.158
Full Text - Weighing risks and rewards en route to the clinic
All good cells come from cells - p248
James L. Sherley
doi:10.1038/ncb0308-248
Full Text - All good cells come from cells | PDF (103 KB) - All good cells come from cells
Offshore stem cell treatments
Sorapop Kiatpongsan & Douglas Sipp
Costs, risks, benefits, and a call for regulation
Published online: 03 December 2008; doi:10.1038/stemcells.2008.151
When the past catches up with the present
Monya Baker
Worries that the NIH did not properly evaluate informed consent by donors of embryos from which stem cell lines were derived throw oversight committees into disarray
Published online: 14 August 2008; doi:10.1038/stemcells.2008.116
Consent issues restrict stem-cell use
Monya Baker
Some human embryonic cell lines may not be eligible for research.
Published online: 28 July 2008; doi:10.1038/454556a
What stem cell therapy can learn from gene therapy
Christopher Scott
Some bioethicists see history repeating itself
Published online: 04 September 2008; doi:10.1038/stemcells.2008.123
Full Text - What stem cell therapy can learn from gene therapy
